Risk factor
Very high price volatility
Profitability factor
Favourable price performance
About
4DMedical Limited operates as a medical technology company in Australia and the United States. It commercializes XV Technology, a four-dimensional lung imaging technology. The company also offers software as a service delivery model; XV lung ventilation analysis software; Permetium, a preclinical imaging system which quantify regional changes in pulmonary function; and AccuVent 200, a small...
Company Valuation
Considering past and projected metrics, the stock is distinctly 'expensive' compared to its peers.
Target Price
The average target price of 4DX.AX is 2.3 and suggests 23% downside potential. Usually, this means a SELL recommendation among investment firms, or a recommendation to de
Buy
Sell